Literature DB >> 2285496

Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

L A Brawn1, C M Castleden.   

Abstract

The incidence of adverse drug reactions increases with aging, and the elderly are more likely to suffer serious or fatal reactions. Thus, morbidity and mortality are considerable in old patients, with 15% of those in hospital suffering a reaction, and many admitted as a consequence of one. The greater propensity of older patients for adverse drug reactions largely reflects the prescription of drugs to them, although over-the-counter purchases must also play a part. The elderly take more drugs per se (which is a reflection of multiple pathology), and more drugs with a narrow therapeutic index associated with a high risk of dangerous adverse reactions and drug interactions. They also have a reduced ability to withstand any reactions due to concomitant disease, and an altered pharmacokinetic and -dynamic response which tends to increase drug effects. The recommendation must be to use fewer drugs in older patients, perhaps trying alternative medicine first in nonacute conditions. Starting doses can often be reduced in the elderly, and clinical and therapeutic monitoring of effect is mandatory. The use of diuretics, antihypertensives, anti-Parkinsonian drugs and anticoagulants emphasise these points, and is discussed in detail together with digoxin, analgesics and nonsteroidal anti-inflammatory drugs. Clear guidelines are given for the use of each of these classes of drug.

Entities:  

Mesh:

Year:  1990        PMID: 2285496     DOI: 10.2165/00002018-199005060-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  88 in total

1.  Age and the pharmacokinetics of morphine.

Authors:  S P Baillie; D N Bateman; P E Coates; K W Woodhouse
Journal:  Age Ageing       Date:  1989-07       Impact factor: 10.668

2.  Effect of naproxen on renal haemodynamics in elderly patients with arthritis.

Authors:  P J Wallis; R Lodwick; S K Sinha; T J Constable
Journal:  Age Ageing       Date:  1989-01       Impact factor: 10.668

3.  The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.

Authors:  D R Robertson; N D Wood; H Everest; K Monks; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

5.  Acute dysphagia induced by bendrofluazide-K.

Authors:  M Ashour; F D Salama; A Morris; J Skinner
Journal:  Practitioner       Date:  1984-05

6.  Intensive monitoring for adverse drug effects in patients discharged from acute medical wards.

Authors:  G S Kellaway; E McCrae
Journal:  N Z Med J       Date:  1973-12-26

7.  Furosemide kinetics and dynamics in aged patients.

Authors:  A L Kerremans; Y Tan; H van Baars; C A van Ginneken; F W Gribnau
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

8.  Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations.

Authors:  J L Juncos; G Fabbrini; M M Mouradian; T N Chase
Journal:  Arch Neurol       Date:  1987-10

9.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors:  R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal:  BMJ       Date:  1988-10-22

10.  Inappropriate prescribing in the elderly.

Authors:  K R Adams; S Al-Hamouz; E Edmund; R C Tallis; C Vellodi; M Lye
Journal:  J R Coll Physicians Lond       Date:  1987-01
View more
  13 in total

1.  Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study.

Authors:  Yvonne Koh; Bte Moideen Kutti Fatimah; Shu Chuen Li
Journal:  Pharm World Sci       Date:  2003-08

Review 2.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

3.  Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis.

Authors:  H Cho; J Myung; H S Suh; H-Y Kang
Journal:  Osteoporos Int       Date:  2018-07-25       Impact factor: 4.507

Review 4.  Labelling deficiencies and communication problems leading to medication misuse in the elderly.

Authors:  B A Kroner; C L Kelley; E M Baranowski
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

Review 5.  The epidemiology of serious adverse drug reactions among the elderly.

Authors:  P A Atkin; P C Veitch; E M Veitch; S J Ogle
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 6.  Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.

Authors:  C M VanDenBerg; Y Kazmi; M W Jann
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

Review 7.  Drug poisoning in older patients. Preventative and management strategies.

Authors:  M B Haselberger; B A Kroner
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

Review 8.  Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Authors:  Danièle Bentué-Ferrer; Olivier Tribut; Elisabeth Polard; Hervé Allain
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Polypharmacy in the aged. Practical solutions.

Authors:  R B Stewart; J W Cooper
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

10.  Pharmacokinetic considerations for digoxin in older people.

Authors:  Geoffrey M Currie; Janelle M Wheat; Hosen Kiat
Journal:  Open Cardiovasc Med J       Date:  2011-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.